Immuno Technologies Inc.
Memphis, TN
- UEI
- XKBBFKJS5796
- CAGE
- 6R5T0
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 3 N Dunlap St Rm C302, Memphis, TN 38103, USA
- Website
- immunotechnologies.com
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Intranasal vaccine against lyme disease - abstract we propose to develop intranasal, parainfluenza 5 (PIV5) viral-vector… | National Institute of Allergy and Infectious Diseases | $4,976,937 | |
| Antibody isotyping for discrimination of disease stage and diagnosis of early lyme disease. | National Institute of Allergy and Infectious Diseases | $1,184,665 | |
| Point of care assay for serodiagnosis of leptospirosis | National Institute of Allergy and Infectious Diseases | $600,000 | |
| Lab on a chip point of care assay for the rapid serodiagnosis of lyme disease | National Institute of Allergy and Infectious Diseases | $3,000,000 |
About Immuno Technologies Inc.
Immuno Technologies Inc. is a US based company that focuses on applied research for infectious diseases, with a main focus on spirochetal diseases such as Lyme Disease and Leptospirosis. The company develops diagnostic assays and prophylactic/preventive agents for these diseases.
Immuno Technologies Inc. has received several prime federal grant awards from the National Institutes of Health, National Institute of Allergy and Infectious Diseases for research and development of vaccines and diagnostics for Lyme disease. One major award aims to develop an intranasal, viral-vector delivered vaccine against Lyme disease called LymeMist, utilizing a modified OspA protein and the safe PIV5 viral vector for needle-free intranasal delivery. Another grant is for antibody isotyping to discriminate disease stage and diagnose early Lyme disease. The company has also received a sub-award from Applied Biotechnology Institute Inc. for evaluating an oral OspA vaccine in mice using OspA-containing corn flour. Immuno Technologies Inc. collaborates with partners and utilizes various approaches, including viral vectors, recombinant proteins, and novel delivery methods, to develop innovative preventive and diagnostic solutions for Lyme and other infectious diseases.
Quick answers
What is Immuno Technologies Inc.'s UEI?
Immuno Technologies Inc.'s Unique Entity ID (UEI) in SAM.gov is XKBBFKJS5796.
What is Immuno Technologies Inc.'s CAGE code?
Immuno Technologies Inc.'s CAGE code is 6R5T0.
What is Immuno Technologies Inc.'s primary NAICS code?
Immuno Technologies Inc.'s primary NAICS code is 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)).
Where is Immuno Technologies Inc. located?
Immuno Technologies Inc.'s physical address in SAM.gov is 3 N Dunlap St Rm C302, Memphis, TN 38103, USA.
Is Immuno Technologies Inc. registered in SAM.gov?
Yes. Immuno Technologies Inc.'s SAM.gov registration is active through October 8, 2027.
What is Immuno Technologies Inc.'s most recent federal award?
Immuno Technologies Inc.'s most recent federal grant award is Intranasal vaccine against lyme disease - abstract we propose to develop intranasal, parainfluenza 5 (PIV5) viral-vector… (R44AI167605), from National Institute of Allergy and Infectious Diseases, on July 12, 2022.
On GovTribe
See Immuno Technologies Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors